Daily Briefing
Tuesday, February 10, 2026
The Vibe
Epic's AI scribe just went live with "strong adoption" across their EHR empire, while Optum launched new AI prior auth tools to cut delays [1][2]. The message is clear: AI is moving from pilot programs to production workflows, and the winners are the platforms already embedded in clinical operations.
Research
•RAMA mortality prediction model for NICU patients with acute kidney injury shows promise, though specific performance metrics weren't disclosed [3]
•Uterine activity patterns can predict preterm birth using AI-assisted models, according to a systematic review of current approaches [4]
•AI successfully deciphers gynecologic cytopathology reports in an exploratory study, potentially enabling automated patient portal communications [5]
•Machine learning models for IgA nephropathy risk prediction are advancing from conventional approaches toward precision nephrology applications [6]
Clinical Practice & Ops
•Epic's integrated AI features are seeing rapid adoption as the EHR giant races to stay ahead of AI innovation cycles [1]
•Optum's new AI-powered prior authorization tools aim to eliminate the delays that plague current approval workflows [2]
•Infinitus launched agentic AI for health plan call centers, personalizing member communications while extending staff capacity [7]
•Bristol Myers Squibb partnered with Evinova's AI-native clinical development platform across their global portfolio to improve trial efficiency [8]
Industry & Products
•Takeda struck a $1.7B deal with Iambic Therapeutics to leverage their AI drug discovery platforms across multiple therapeutic areas [9]
•Hims & Hers added Grail's Galleri multi-cancer blood test to their digital health platform, expanding direct-to-consumer cancer screening [10]
One to Watch
Monitor Epic's AI scribe rollout metrics — if adoption rates hold, this could accelerate the shift from physician resistance to AI dependency across ambulatory care.